Key Takeaway
Exogenous ketones show promise for cognitive function in MCI/Alzheimer's, though study heterogeneity limits firm conclusions.
Summary
This 2025 systematic review examined the efficacy and safety of exogenous ketones for cognitive function in mild cognitive impairment and Alzheimer's disease. Improvements were observed across multiple cognitive domains, though heterogeneity limits firm conclusions.